The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Nektar Therapeutics

Nasdaq: NKTR
Last

(U.S.) $15.64

Today's change-0.04 -0.26%
Updated May 2 9:51 AM EDT. Delayed by at least 15 minutes.
 

Nektar Therapeutics

Nasdaq: NKTR
Last

(U.S.) $15.64

Today's change-0.04 -0.26%
Updated May 2 9:51 AM EDT. Delayed by at least 15 minutes.

Nektar Therapeutics down (U.S.)$0.04

Nektar Therapeutics is lower today, dropping (U.S.)$0.04 or 0.26% to (U.S.)$15.64. Over the last five days, shares have lost 3.46% and are down 7.18% for the last year to date. This security has outperformed the S&P 500 by 38.18% during the last year.

Key company metrics

  • Open(U.S.) $15.84
  • Previous close(U.S.) $15.68
  • High(U.S.) $15.84
  • Low(U.S.) $15.44
  • Bid / Ask(U.S.) $15.64 / (U.S.) $15.68
  • YTD % change-7.18%
  • Volume87,082
  • Average volume (10-day)904,556
  • Average volume (1-month)1,099,843
  • Average volume (3-month)1,591,641
  • 52-week range(U.S.) $9.16 to (U.S.) $17.55
  • Beta1.80
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.62
Updated May 2 9:51 AM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue396023109
Total other revenue--------
Total revenue396023109
Gross profit315312100
Total cost of revenue87118
Total operating expense83606666
Selling / general / administrative13101010
Research & development47434547
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)14------
Other operating expenses, total--------
Operating income-430-4343
Interest income (expense), net non-operating-11-9-9-9
Gain (loss) on sale of assets--------
Other--------
Income before tax-54-8-5234
Income after tax-54-8-5334
Income tax, total0000
Net income-54-8-5334
Total adjustments to net income--------
Net income before extra. items-54-8-5334
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-54-8-5334
Inc. avail. to common incl. extra. items-54-8-5334
Diluted net income-54-8-5334
Dilution adjustment--------
Diluted weighted average shares134133132136
Diluted EPS excluding extraordinary itemsvalue per share-0.40-0.06-0.400.25
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.34-0.06-0.400.25